Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Denmark’s C25 index opened in the red on Tuesday following the Easter holiday. Just a quarter of an hour after the market ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...

Amid a grim day on the stock market, consumer confidence shows that Danes are pessimistic about the future.According to ...

Russian public procurements of drugs based on the active ingredient semaglutide, which is an original drug from Denmark’s ...